Curriculum Breadth and Versatility
Penn's cross-disciplinary approach echoes the nature of biotechnology, an interdisciplinary field contributed to by biology, biochemistry, chemical engineering, bioengineering, computer and information science and plant science. The Biotechnology Program exposes students to the broad range of biotechnology, giving them both the skills and knowledge they need to assume leadership in the pharmaceutical and biotechnology industries. As a student, you can:
- Tailor your studies to your existing or future career in
biotechnology. Each student selects one of four parallel tracks--1)
molecular biotechnology, 2) biomedical technologies, 3) engineering
biotechnology and 4) computational biology/ bioinformatics. The
first track emphasizes molecular biology. The biomedical technologies
track focuses on clinical issues such as biomaterial, tissue engineering,
and imaging. The engineering track stresses bioprocess engineering
and drug discovery, which is central to pharmaceutical industry.
The computational biology and bioinformatics track prepares students
for analysis of ever-expanding genomic databases. Core courses
common to all tracks insure each student's exposure to the fundamentals
of biotechnology.
- Benefit from interaction with a diverse student base.
This program's cross-disciplinary approach attracts students from
a wide range of backgrounds including biology, chemistry, computer
science, and engineering. These different perspectives add to
the learning experience.
- Develop the ability to look at projects from various biotechnology
perspectives. In today's workplace where working in teams across
disciplines is key, multidisciplinary training prepares students for
the flexibility and versatility they need for business success.
- Get an understanding of the issues you need to tackle to bring
product to market. You will attend seminars that keep you up-to-date
with the latest scientific, regulatory and ethical issues in biotechnology.
In these seminars, you will learn about drug discovery, elements of
pharmaceutical patent law, designing clinical trials and the FDA approval
process.
|